Request for Covid-19 Impact Assessment of this Report
The United States Immunology Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Immunology Drug market, reaching US$ million by the year 2028. As for the Europe Immunology Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Immunology Drug players cover Abbott Laboratories, Active Biotech, Eli Lilly and Company, and Autoimmune Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunology Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Cancer Research Centers and Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immunology Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Immunology Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Immunology Drug by Country/Region, 2017, 2022 & 2028
2.2 Immunology Drug Segment by Type
2.2.1 Monoclonal Antibodies (mAb)
2.2.2 Antibody Drug Conjugates
2.2.3 Immunosuppressive medication
2.2.4 Others
2.3 Immunology Drug Sales by Type
2.3.1 Global Immunology Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Immunology Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Immunology Drug Sale Price by Type (2017-2022)
2.4 Immunology Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Cancer Research Centers and Institutes
2.5 Immunology Drug Sales by Application
2.5.1 Global Immunology Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Immunology Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Immunology Drug Sale Price by Application (2017-2022)
3 Global Immunology Drug by Company
3.1 Global Immunology Drug Breakdown Data by Company
3.1.1 Global Immunology Drug Annual Sales by Company (2020-2022)
3.1.2 Global Immunology Drug Sales Market Share by Company (2020-2022)
3.2 Global Immunology Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Immunology Drug Revenue by Company (2020-2022)
3.2.2 Global Immunology Drug Revenue Market Share by Company (2020-2022)
3.3 Global Immunology Drug Sale Price by Company
3.4 Key Manufacturers Immunology Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunology Drug Product Location Distribution
3.4.2 Players Immunology Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Immunology Drug by Geographic Region
4.1 World Historic Immunology Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Immunology Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Immunology Drug Annual Revenue by Geographic Region
4.2 World Historic Immunology Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Immunology Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Immunology Drug Annual Revenue by Country/Region
4.3 Americas Immunology Drug Sales Growth
4.4 APAC Immunology Drug Sales Growth
4.5 Europe Immunology Drug Sales Growth
4.6 Middle East & Africa Immunology Drug Sales Growth
5 Americas
5.1 Americas Immunology Drug Sales by Country
5.1.1 Americas Immunology Drug Sales by Country (2017-2022)
5.1.2 Americas Immunology Drug Revenue by Country (2017-2022)
5.2 Americas Immunology Drug Sales by Type
5.3 Americas Immunology Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunology Drug Sales by Region
6.1.1 APAC Immunology Drug Sales by Region (2017-2022)
6.1.2 APAC Immunology Drug Revenue by Region (2017-2022)
6.2 APAC Immunology Drug Sales by Type
6.3 APAC Immunology Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Immunology Drug by Country
7.1.1 Europe Immunology Drug Sales by Country (2017-2022)
7.1.2 Europe Immunology Drug Revenue by Country (2017-2022)
7.2 Europe Immunology Drug Sales by Type
7.3 Europe Immunology Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immunology Drug by Country
8.1.1 Middle East & Africa Immunology Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Immunology Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Immunology Drug Sales by Type
8.3 Middle East & Africa Immunology Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunology Drug
10.3 Manufacturing Process Analysis of Immunology Drug
10.4 Industry Chain Structure of Immunology Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunology Drug Distributors
11.3 Immunology Drug Customer
12 World Forecast Review for Immunology Drug by Geographic Region
12.1 Global Immunology Drug Market Size Forecast by Region
12.1.1 Global Immunology Drug Forecast by Region (2023-2028)
12.1.2 Global Immunology Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immunology Drug Forecast by Type
12.7 Global Immunology Drug Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Immunology Drug Product Offered
13.1.3 Abbott Laboratories Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Active Biotech
13.2.1 Active Biotech Company Information
13.2.2 Active Biotech Immunology Drug Product Offered
13.2.3 Active Biotech Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Active Biotech Main Business Overview
13.2.5 Active Biotech Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Immunology Drug Product Offered
13.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Autoimmune Inc.
13.4.1 Autoimmune Inc. Company Information
13.4.2 Autoimmune Inc. Immunology Drug Product Offered
13.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Autoimmune Inc. Main Business Overview
13.4.5 Autoimmune Inc. Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Immunology Drug Product Offered
13.5.3 Pfizer Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 GlaxoSmithKline plc
13.6.1 GlaxoSmithKline plc Company Information
13.6.2 GlaxoSmithKline plc Immunology Drug Product Offered
13.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GlaxoSmithKline plc Main Business Overview
13.6.5 GlaxoSmithKline plc Latest Developments
13.7 Seattle Genetics
13.7.1 Seattle Genetics Company Information
13.7.2 Seattle Genetics Immunology Drug Product Offered
13.7.3 Seattle Genetics Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Seattle Genetics Main Business Overview
13.7.5 Seattle Genetics Latest Developments
13.8 Genentech
13.8.1 Genentech Company Information
13.8.2 Genentech Immunology Drug Product Offered
13.8.3 Genentech Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Genentech Main Business Overview
13.8.5 Genentech Latest Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 F. Hoffmann-La Roche Ltd. Company Information
13.9.2 F. Hoffmann-La Roche Ltd. Immunology Drug Product Offered
13.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.9.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.10 Eisai Co.
13.10.1 Eisai Co. Company Information
13.10.2 Eisai Co. Immunology Drug Product Offered
13.10.3 Eisai Co. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Eisai Co. Main Business Overview
13.10.5 Eisai Co. Latest Developments
13.11 Bayer AG
13.11.1 Bayer AG Company Information
13.11.2 Bayer AG Immunology Drug Product Offered
13.11.3 Bayer AG Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bayer AG Main Business Overview
13.11.5 Bayer AG Latest Developments
13.12 Sanofi Aventis LLC.
13.12.1 Sanofi Aventis LLC. Company Information
13.12.2 Sanofi Aventis LLC. Immunology Drug Product Offered
13.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sanofi Aventis LLC. Main Business Overview
13.12.5 Sanofi Aventis LLC. Latest Developments
14 Research Findings and Conclusion
Table 1. Immunology Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Immunology Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (mAb)
Table 4. Major Players of Antibody Drug Conjugates
Table 5. Major Players of Immunosuppressive medication
Table 6. Major Players of Others
Table 7. Global Immunology Drug Sales by Type (2017-2022) & (MT)
Table 8. Global Immunology Drug Sales Market Share by Type (2017-2022)
Table 9. Global Immunology Drug Revenue by Type (2017-2022) & ($ million)
Table 10. Global Immunology Drug Revenue Market Share by Type (2017-2022)
Table 11. Global Immunology Drug Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Immunology Drug Sales by Application (2017-2022) & (MT)
Table 13. Global Immunology Drug Sales Market Share by Application (2017-2022)
Table 14. Global Immunology Drug Revenue by Application (2017-2022)
Table 15. Global Immunology Drug Revenue Market Share by Application (2017-2022)
Table 16. Global Immunology Drug Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Immunology Drug Sales by Company (2020-2022) & (MT)
Table 18. Global Immunology Drug Sales Market Share by Company (2020-2022)
Table 19. Global Immunology Drug Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Immunology Drug Revenue Market Share by Company (2020-2022)
Table 21. Global Immunology Drug Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Immunology Drug Producing Area Distribution and Sales Area
Table 23. Players Immunology Drug Products Offered
Table 24. Immunology Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Immunology Drug Sales by Geographic Region (2017-2022) & (MT)
Table 28. Global Immunology Drug Sales Market Share Geographic Region (2017-2022)
Table 29. Global Immunology Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Immunology Drug Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Immunology Drug Sales by Country/Region (2017-2022) & (MT)
Table 32. Global Immunology Drug Sales Market Share by Country/Region (2017-2022)
Table 33. Global Immunology Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Immunology Drug Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Immunology Drug Sales by Country (2017-2022) & (MT)
Table 36. Americas Immunology Drug Sales Market Share by Country (2017-2022)
Table 37. Americas Immunology Drug Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Immunology Drug Revenue Market Share by Country (2017-2022)
Table 39. Americas Immunology Drug Sales by Type (2017-2022) & (MT)
Table 40. Americas Immunology Drug Sales Market Share by Type (2017-2022)
Table 41. Americas Immunology Drug Sales by Application (2017-2022) & (MT)
Table 42. Americas Immunology Drug Sales Market Share by Application (2017-2022)
Table 43. APAC Immunology Drug Sales by Region (2017-2022) & (MT)
Table 44. APAC Immunology Drug Sales Market Share by Region (2017-2022)
Table 45. APAC Immunology Drug Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Immunology Drug Revenue Market Share by Region (2017-2022)
Table 47. APAC Immunology Drug Sales by Type (2017-2022) & (MT)
Table 48. APAC Immunology Drug Sales Market Share by Type (2017-2022)
Table 49. APAC Immunology Drug Sales by Application (2017-2022) & (MT)
Table 50. APAC Immunology Drug Sales Market Share by Application (2017-2022)
Table 51. Europe Immunology Drug Sales by Country (2017-2022) & (MT)
Table 52. Europe Immunology Drug Sales Market Share by Country (2017-2022)
Table 53. Europe Immunology Drug Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Immunology Drug Revenue Market Share by Country (2017-2022)
Table 55. Europe Immunology Drug Sales by Type (2017-2022) & (MT)
Table 56. Europe Immunology Drug Sales Market Share by Type (2017-2022)
Table 57. Europe Immunology Drug Sales by Application (2017-2022) & (MT)
Table 58. Europe Immunology Drug Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Immunology Drug Sales by Country (2017-2022) & (MT)
Table 60. Middle East & Africa Immunology Drug Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Immunology Drug Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Immunology Drug Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Immunology Drug Sales by Type (2017-2022) & (MT)
Table 64. Middle East & Africa Immunology Drug Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Immunology Drug Sales by Application (2017-2022) & (MT)
Table 66. Middle East & Africa Immunology Drug Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Immunology Drug
Table 68. Key Market Challenges & Risks of Immunology Drug
Table 69. Key Industry Trends of Immunology Drug
Table 70. Immunology Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Immunology Drug Distributors List
Table 73. Immunology Drug Customer List
Table 74. Global Immunology Drug Sales Forecast by Region (2023-2028) & (MT)
Table 75. Global Immunology Drug Sales Market Forecast by Region
Table 76. Global Immunology Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Immunology Drug Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Immunology Drug Sales Forecast by Country (2023-2028) & (MT)
Table 79. Americas Immunology Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Immunology Drug Sales Forecast by Region (2023-2028) & (MT)
Table 81. APAC Immunology Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Immunology Drug Sales Forecast by Country (2023-2028) & (MT)
Table 83. Europe Immunology Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Immunology Drug Sales Forecast by Country (2023-2028) & (MT)
Table 85. Middle East & Africa Immunology Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Immunology Drug Sales Forecast by Type (2023-2028) & (MT)
Table 87. Global Immunology Drug Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Immunology Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Immunology Drug Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Immunology Drug Sales Forecast by Application (2023-2028) & (MT)
Table 91. Global Immunology Drug Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Immunology Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Immunology Drug Revenue Market Share Forecast by Application (2023-2028)
Table 94. Abbott Laboratories Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbott Laboratories Immunology Drug Product Offered
Table 96. Abbott Laboratories Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. Abbott Laboratories Main Business
Table 98. Abbott Laboratories Latest Developments
Table 99. Active Biotech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Active Biotech Immunology Drug Product Offered
Table 101. Active Biotech Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 102. Active Biotech Main Business
Table 103. Active Biotech Latest Developments
Table 104. Eli Lilly and Company Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Company Immunology Drug Product Offered
Table 106. Eli Lilly and Company Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 107. Eli Lilly and Company Main Business
Table 108. Eli Lilly and Company Latest Developments
Table 109. Autoimmune Inc. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Autoimmune Inc. Immunology Drug Product Offered
Table 111. Autoimmune Inc. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 112. Autoimmune Inc. Main Business
Table 113. Autoimmune Inc. Latest Developments
Table 114. Pfizer Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Pfizer Immunology Drug Product Offered
Table 116. Pfizer Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 117. Pfizer Main Business
Table 118. Pfizer Latest Developments
Table 119. GlaxoSmithKline plc Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. GlaxoSmithKline plc Immunology Drug Product Offered
Table 121. GlaxoSmithKline plc Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 122. GlaxoSmithKline plc Main Business
Table 123. GlaxoSmithKline plc Latest Developments
Table 124. Seattle Genetics Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Seattle Genetics Immunology Drug Product Offered
Table 126. Seattle Genetics Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 127. Seattle Genetics Main Business
Table 128. Seattle Genetics Latest Developments
Table 129. Genentech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Genentech Immunology Drug Product Offered
Table 131. Genentech Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 132. Genentech Main Business
Table 133. Genentech Latest Developments
Table 134. F. Hoffmann-La Roche Ltd. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. F. Hoffmann-La Roche Ltd. Immunology Drug Product Offered
Table 136. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 137. F. Hoffmann-La Roche Ltd. Main Business
Table 138. F. Hoffmann-La Roche Ltd. Latest Developments
Table 139. Eisai Co. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Eisai Co. Immunology Drug Product Offered
Table 141. Eisai Co. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 142. Eisai Co. Main Business
Table 143. Eisai Co. Latest Developments
Table 144. Bayer AG Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Bayer AG Immunology Drug Product Offered
Table 146. Bayer AG Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 147. Bayer AG Main Business
Table 148. Bayer AG Latest Developments
Table 149. Sanofi Aventis LLC. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors
Table 150. Sanofi Aventis LLC. Immunology Drug Product Offered
Table 151. Sanofi Aventis LLC. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 152. Sanofi Aventis LLC. Main Business
Table 153. Sanofi Aventis LLC. Latest Developments
List of Figures
Figure 1. Picture of Immunology Drug
Figure 2. Immunology Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunology Drug Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Immunology Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Immunology Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibodies (mAb)
Figure 10. Product Picture of Antibody Drug Conjugates
Figure 11. Product Picture of Immunosuppressive medication
Figure 12. Product Picture of Others
Figure 13. Global Immunology Drug Sales Market Share by Type in 2021
Figure 14. Global Immunology Drug Revenue Market Share by Type (2017-2022)
Figure 15. Immunology Drug Consumed in Hospitals
Figure 16. Global Immunology Drug Market: Hospitals (2017-2022) & (MT)
Figure 17. Immunology Drug Consumed in Clinics
Figure 18. Global Immunology Drug Market: Clinics (2017-2022) & (MT)
Figure 19. Immunology Drug Consumed in Cancer Research Centers and Institutes
Figure 20. Global Immunology Drug Market: Cancer Research Centers and Institutes (2017-2022) & (MT)
Figure 21. Global Immunology Drug Sales Market Share by Application (2017-2022)
Figure 22. Global Immunology Drug Revenue Market Share by Application in 2021
Figure 23. Immunology Drug Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Immunology Drug Revenue Market Share by Company in 2021
Figure 25. Global Immunology Drug Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Immunology Drug Revenue Market Share by Geographic Region in 2021
Figure 27. Global Immunology Drug Sales Market Share by Region (2017-2022)
Figure 28. Global Immunology Drug Revenue Market Share by Country/Region in 2021
Figure 29. Americas Immunology Drug Sales 2017-2022 (MT)
Figure 30. Americas Immunology Drug Revenue 2017-2022 ($ Millions)
Figure 31. APAC Immunology Drug Sales 2017-2022 (MT)
Figure 32. APAC Immunology Drug Revenue 2017-2022 ($ Millions)
Figure 33. Europe Immunology Drug Sales 2017-2022 (MT)
Figure 34. Europe Immunology Drug Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Immunology Drug Sales 2017-2022 (MT)
Figure 36. Middle East & Africa Immunology Drug Revenue 2017-2022 ($ Millions)
Figure 37. Americas Immunology Drug Sales Market Share by Country in 2021
Figure 38. Americas Immunology Drug Revenue Market Share by Country in 2021
Figure 39. United States Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Immunology Drug Sales Market Share by Region in 2021
Figure 44. APAC Immunology Drug Revenue Market Share by Regions in 2021
Figure 45. China Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Immunology Drug Sales Market Share by Country in 2021
Figure 52. Europe Immunology Drug Revenue Market Share by Country in 2021
Figure 53. Germany Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Immunology Drug Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Immunology Drug Revenue Market Share by Country in 2021
Figure 60. Egypt Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Immunology Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Immunology Drug in 2021
Figure 66. Manufacturing Process Analysis of Immunology Drug
Figure 67. Industry Chain Structure of Immunology Drug
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...